As at 31st January 2017 the Company’s issued share capital consists of 64,340,798 ordinary shares with a nominal value of £0.003 each (“Ordinary Shares”), each share having equal voting rights.
The Company does not hold any Ordinary shares or treasury shares.
In accordance with AIM Rule 26, in so far as the Company is aware, the percentage of the Company’s issued share capital that is not in public hands is 87.6%.
There are no restrictions on the transfer of securities.
Never miss an update from Mereo. Sign up for and select the type of alerts you would like to receive by email.Register for Email Alerts
Share Price Information
Mereo is a specialty biopharma company developing innovative medicines for patients. Find out about our share price and latest trades.View Share Price